These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15316799)

  • 1. Genetic variation in apolipoprotein D and Alzheimer's disease.
    Helisalmi S; Hiltunen M; Vepsäläinen S; Iivonen S; Corder EH; Lehtovirta M; Mannermaa A; Koivisto AM; Soininen H
    J Neurol; 2004 Aug; 251(8):951-7. PubMed ID: 15316799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic association between APOA1 and APOD polymorphisms and Alzheimer's disease in a Japanese population.
    Shibata N; Nagata T; Shinagawa S; Ohnuma T; Shimazaki H; Komatsu M; Kuerban B; Tomson K; Nakayama K; Yamada H; Arai H
    J Neural Transm (Vienna); 2013 Nov; 120(11):1599-603. PubMed ID: 23690001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in apolipoprotein D affects the risk of Alzheimer disease in African-Americans.
    Desai PP; Hendrie HC; Evans RM; Murrell JR; DeKosky ST; Kamboh MI
    Am J Med Genet B Neuropsychiatr Genet; 2003 Jan; 116B(1):98-101. PubMed ID: 12497622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression.
    Caraci F; Bosco P; Signorelli M; Spada RS; Cosentino FI; Toscano G; Bonforte C; Muratore S; Prestianni G; Panerai S; Giambirtone MC; Gulotta E; Romano C; Salluzzo MG; Nicoletti F; Copani A; Drago F; Aguglia E; Ferri R
    Eur Neuropsychopharmacol; 2012 Apr; 22(4):281-9. PubMed ID: 21924590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between polymorphisms in the apolipoprotein D gene and sporadic Alzheimer's disease.
    Chen Y; Jia L; Wei C; Wang F; Lv H; Jia J
    Brain Res; 2008 Oct; 1233():196-202. PubMed ID: 18671953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: no relation to apolipoprotein E expression or genotype.
    Thomas EA; Laws SM; Sutcliffe JG; Harper C; Dean B; McClean C; Masters C; Lautenschlager N; Gandy SE; Martins RN
    Biol Psychiatry; 2003 Jul; 54(2):136-41. PubMed ID: 12873803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
    Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
    Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients.
    Terrisse L; Poirier J; Bertrand P; Merched A; Visvikis S; Siest G; Milne R; Rassart E
    J Neurochem; 1998 Oct; 71(4):1643-50. PubMed ID: 9751198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
    Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
    Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte-specific protein tyrosine kinase is a novel risk gene for Alzheimer disease.
    Zhong W; Yamagata HD; Taguchi K; Akatsu H; Kamino K; Yamamoto T; Kosaka K; Takeda M; Kondo I; Miki T
    J Neurol Sci; 2005 Nov; 238(1-2):53-7. PubMed ID: 16109429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gene encoding nicastrin, a major gamma-secretase component, modifies risk for familial early-onset Alzheimer disease in a Dutch population-based sample.
    Dermaut B; Theuns J; Sleegers K; Hasegawa H; Van den Broeck M; Vennekens K; Corsmit E; St George-Hyslop P; Cruts M; van Duijn CM; Van Broeckhoven C
    Am J Hum Genet; 2002 Jun; 70(6):1568-74. PubMed ID: 11992262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease.
    Brickell KL; Steinbart EJ; Rumbaugh M; Payami H; Schellenberg GD; Van Deerlin V; Yuan W; Bird TD
    Arch Neurol; 2006 Sep; 63(9):1307-11. PubMed ID: 16966510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E phenotypes in healthy normal controls and demented subjects with Alzheimer's disease and vascular dementia in Mie Prefecture of Japan.
    Nakayama S; Kuzuhara S
    Psychiatry Clin Neurosci; 1999 Dec; 53(6):643-8. PubMed ID: 10687744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease.
    van Duijn CM; de Knijff P; Cruts M; Wehnert A; Havekes LM; Hofman A; Van Broeckhoven C
    Nat Genet; 1994 May; 7(1):74-8. PubMed ID: 8075646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease.
    Helisalmi S; Tarvainen T; Vepsäläinen S; Koivisto AM; Hiltunen M; Soininen H
    Neurosci Lett; 2008 Aug; 441(2):233-6. PubMed ID: 18573313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.
    Zhang Q; Yu JT; Zhu QX; Zhang W; Wu ZC; Miao D; Tan L
    Brain Res; 2010 Aug; 1348():216-21. PubMed ID: 20558149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators.
    Borroni B; Archetti S; Agosti C; Akkawi N; Brambilla C; Caimi L; Caltagirone C; Di Luca M; Padovani A
    Neurobiol Aging; 2004 Jul; 25(6):747-51. PubMed ID: 15165699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
    Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
    Cui T; Zhou X; Jin W; Zheng F; Cao X
    Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.